Clinical Trial

Trial Protocol ID USOR 22041_M23-362

Trial Description

A Phase 2, Open-Label Trial to Evaluate Safety of Epcoritamab Monotherapy in Subjects with Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma Grade 1-3a when Administered in the Outpatient Setting

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Syed Shahid Mahmood, M.D.

Disease Types

Sponsor

  • AbbVie

ClinicalTrials.gov NCT ID

  • NCT05451810